Patient-derived 2D & 3D cell models for peripheral neuropathies
Commonly used acronym: SCREEN4PN
Scope of the method
- Human health
- Basic Research
- Education and training
- Translational - Applied Research
- In vitro - Ex vivo
- Human derived cells / tissues / organs
Description
- Neuromuscular junction
- Peripheral neuropathy
- Schwann cells
- iPSC-derived neurons
- myelination
- axonal degeneration
- organoids
- demyelination
- remyelination
- biomedical research
- Induced pluripotent stem cells
- 3D organoid models
- neuromuscular assembloids
Inherited peripheral neuropathies (IPNs) are a group of diseases associated with mutations in various genes with fundamental roles in the development and function of peripheral nerves. Over the past 10 years, significant advances in identifying molecular disease mechanisms underlying axonal and myelin degeneration, acquired from cellular biology studies and transgenic fly and rodent models, have facilitated the development of promising treatment strategies. However, no clinical treatment has emerged to date. This lack of treatment highlights the urgent need for more biologically and clinically relevant models recapitulating IPNs. For both neurodevelopmental and neurodegenerative diseases, patient-specific induced pluripotent stem cells (iPSCs) are a particularly powerful platform for disease modeling and preclinical studies. In our laboratory, we are currently developing human derived organoid models as a tool to gain for novel insights in the disease mechanisms of hereditary neuromyopathies and validate therapeutic molecules.
- Still in development
Pros, cons & Future potential
We replace and reduce the development of animal models by creating human derived organoids.
References, associated documents and other information
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs. Van Lent J, Prior R, Pérez Siles G, Cutrupi AN, Kennerson ML, Vangansewinkel T, Wolfs E, Mukherjee-Clavin B, Nevin Z, Judge L, Conklin B, Tyynismaa H, Clark AJ, Bennett DL, Van Den Bosch L, Saporta M, Timmerman V. Experimental Molecular Medicine, 2024;56(6):1348-1364. doi: 10.1038/s12276-024-01250-x
Contact person
Vincent TimmermanOrganisations
University of Antwerp (UAntwerpen)Departement Biomedische Wetenschappen
Peripheral Neuropathy Research Group
Belgium
Flemish Region